Hi, sir. Congrats on good set. Wanted to understand again on the product level margin, are we seeing improvement in any of the product margin because even we are ULIP heavy, so we have managed to deliver a decent s et and would this mean that this will become base margin going ahead, you can see further improvement with the mix improving in FY '25?
So another two products which you talked about which you have launched in this quarter, which means April running quarterly are basically focusing on the pure protection plan rather than ROP if I get it correct?